UBS Group’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17M Sell
684,551
-47,835
-7% -$1.24M ﹤0.01% 2780
2025
Q4
$18.6M Buy
732,386
+6,213
+0.9% +$139K ﹤0.01% 2647
2025
Q3
$11.7M Buy
726,173
+54,889
+8% +$889K ﹤0.01% 3119
2025
Q2
$10.7M Sell
671,284
-60,569
-8% -$916K ﹤0.01% 3018
2025
Q1
$12.5M Buy
731,853
+141,089
+24% +$2.95M ﹤0.01% 2818
2024
Q4
$14.6M Buy
590,764
+449,775
+319% +$12.8M ﹤0.01% 2664
2024
Q3
$4.02M Buy
140,989
+21,634
+18% +$638K ﹤0.01% 3296
2024
Q2
$3.15M Sell
119,355
-83,195
-41% -$2.37M ﹤0.01% 3301
2024
Q1
$6.54M Buy
202,550
+47,468
+31% +$1.73M ﹤0.01% 2682
2023
Q4
$6.53M Buy
155,082
+70,285
+83% +$2.59M ﹤0.01% 2476
2023
Q3
$3.26M Sell
84,797
-7,138
-8% -$161K ﹤0.01% 2982
2023
Q2
$1.74M Sell
91,935
-31,101
-25% -$580K ﹤0.01% 3670
2023
Q1
$1.91M Sell
123,036
-30,839
-20% -$535K ﹤0.01% 3484
2022
Q4
$2.73M Buy
153,875
+146,897
+2,105% +$1.85M ﹤0.01% 3069
2022
Q3
$39K Buy
6,978
+4,695
+206% +$22.9K ﹤0.01% 6587
2022
Q2
$9K Buy
+2,283
New +$9.86K ﹤0.01% 8138
2022
Q1
Sell
-166,534
Closed -$1.42M 10542
2021
Q4
$1.42M Buy
166,534
+117,796
+242% +$972K ﹤0.01% 4070
2021
Q3
$423K Buy
48,738
+12,095
+33% +$109K ﹤0.01% 4842
2021
Q2
$387K Sell
36,643
-46,487
-56% -$649K ﹤0.01% 4909
2021
Q1
$1.33M Buy
83,130
+33,895
+69% +$894K ﹤0.01% 3956
2020
Q4
$2.27M Buy
49,235
+48,396
+5,768% +$2.24M ﹤0.01% 3298
2020
Q3
$30K Sell
839
-6,116
-88% -$184K ﹤0.01% 5991
2020
Q2
$169K Buy
6,955
+4,598
+195% +$98.5K ﹤0.01% 4919
2020
Q1
$37K Buy
2,357
+1,281
+119% +$19.3K ﹤0.01% 6065
2019
Q4
$17K Buy
+1,076
New +$12.1K ﹤0.01% 6988

Other funds holding IMVT